Three New Crown Vaccine Manufacturing Company Due to patent disputes,

Jimu Journalist Hu Li

According to BBC reports on August 26, American Biotechnology Company Moderna (Modner) was violated for patent rights for new coronary pneumonia virus vaccine and was suing its German partner Balionta and Pfizer.

Data chart (source: BBC)

Moderna believes that in the development of the first new crown vaccine, Balion Tai and Pfizer infringed their patent rights and directly copied the MRNA technology that Moderna obtained patent from 2010 to 2016, involving two types of patents, including the MRNA structure involving the MRNA structure. Another encoding a full -length spiny protein, Moderna claims that its scientists have developed this protein when developing MERS (Middle East respiratory syndrome) vaccine.

It is reported that MRNA (messenger ribonic acid) is an important substance with genetic information that can guide protein synthesis. Since the epidemic of new crown pneumonia, the new crown vaccine developed by MRNA technology has played a great role in controlling the epidemic.

After Moderna prosecuted Pfizer, a spokesman for Pfizer said: "We are still confident in intellectual property rights that support Pfizer vaccine. In the face of litigation allegations, they will vigorously defend their rights and interests."

In addition, after Moderna's prosecution of Caliantai's announcement, Pionee's stock price fell more than 2%, and Pfizer's stock price fell more than 1%.

- END -